Metraipolis › archive › dc_e6d73d2a1844

Exploring the pharmacological mechanisms of resibufogenin in castration-resistant prostate cancer via network pharmacology and experimental validation — Europe PMC PMID:42057817

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42057817
DOI
10.3389/fonc.2026.1799626
License (as archived)
solo-consultazione
Archived
2026-10-08T01:47:06.699Z
SHA-256 of the archived text
5fa128d04d9da3b065f156cfc2b944a7134b3ae0cebfa0514f6562416f58aeb7
Stable URL of this page
https://metraipolis.com/documento/dc_e6d73d2a1844

How to cite

Exploring the pharmacological mechanisms of resibufogenin in castration-resistant prostate cancer via network pharmacology and experimental validation — Europe PMC PMID:42057817 — Europe PMC (en), https://europepmc.org/article/MED/42057817 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e6d73d2a1844 (Metraipolis archive dc_e6d73d2a1844, sha256 5fa128d04d9da3b065f156cfc2b944a7134b3ae0cebfa0514f6562416f58aeb7)
BibTeX
@misc{dce6d73d2a1844,
  title = {Exploring the pharmacological mechanisms of resibufogenin in castration-resistant prostate cancer via network pharmacology and experimental validation — Europe PMC PMID:42057817},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42057817},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e6d73d2a1844; sha256 5fa128d04d9da3b065f156cfc2b944a7134b3ae0cebfa0514f6562416f58aeb7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42057817. Agents can read the archived copy with the MCP tool read_document.